Literature DB >> 19800665

T-786C polymorphism in promoter of eNOS gene as genetic risk factor in patients with erectile dysfunction in Turkish population.

Incilay Sinici1, E Oğuz Güven, Egecan Serefoğlu, Mutlu Hayran.   

Abstract

OBJECTIVES: To investigate the effect of 2 endothelial nitric oxide synthase gene polymorphisms, namely, variable number of 27-bp tandem repeats in intron 4 and T-786C in the promoter region, on the susceptibility to erectile dysfunction (ED) in Turkish population.
METHODS: A total of 72 patients with ED (mean age 54.3 +/- 9.2 years) diagnosed by Doppler ultrasonography and 71 healthy controls (mean age 55.4 +/- 8.2 years) were analyzed. Genotypes were determined through polymerase chain reaction with or without restriction endonuclease digestions.
RESULTS: Genotype distribution for CC genotype of T-786C polymorphism in promoter was significantly different between patients with ED and controls, the genotype frequency being 31.9% and 12.7%, respectively (P = .019). The univariate odds ratio (OR) associated with CC alleles revealed 3 times increased risk for ED (OR = 3.2; 95% confidence interval [CI], 1.4-7.6; P = .006). The risk also holds when excluding patients with hypertension and diabetes mellitus (P = .012, OR = 3.1; 95% CI, 1.2-7.7) as well as obesity (P = .05, OR = 4; 95% CI, 1.05-15.3). Patients with CC genotype of promoter present earlier symptoms of ED (51.7%) compared with controls (10.7%) (P <.001). No significant correlation was observed with variable number of tandem repeats in intron 4 and with the type of vascular insufficiency.
CONCLUSIONS: The CC genotype of T-786C polymorphism in the promoter of eNOS gene is associated with increased risk of ED in Turkish population. Earlier onset of ED with CC genotype suggests that CC allele is an independent risk factor for endothelial dysfunction in the absence of other risk factors (hypertension, diabetes mellitus, obesity). An impaired NO production because of CC alleles may account for pathophysiology of ED. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19800665     DOI: 10.1016/j.urology.2009.06.063

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  7 in total

1.  Endothelial nitric oxide synthase gene polymorphisms and prostate cancer risk in Serbian population.

Authors:  Ana Branković; Goran Brajušković; Zorana Nikolić; Vinka Vukotić; Snežana Cerović; Dušanka Savić-Pavićević; Stanka Romac
Journal:  Int J Exp Pathol       Date:  2013-09-02       Impact factor: 1.925

Review 2.  [Genetic aspects of erectile dysfunction].

Authors:  A Eisenhardt; H Sperling; H Rübben
Journal:  Urologe A       Date:  2015-05       Impact factor: 0.639

Review 3.  Genetics of resistant hypertension: a novel pharmacogenomics phenotype.

Authors:  Nihal El Rouby; Rhonda M Cooper-DeHoff
Journal:  Curr Hypertens Rep       Date:  2015-09       Impact factor: 5.369

Review 4.  Genetics and erectile dysfunction: leveraging early foundations for new discoveries.

Authors:  Darshan P Patel; Alexander W Pastuszak; James M Hotaling
Journal:  Int J Impot Res       Date:  2020-11-10       Impact factor: 2.896

Review 5.  Association of endothelial nitric oxide synthase polymorphisms with an increased risk of erectile dysfunction.

Authors:  Lei Gao; Zhifeng Zhao; Fengfu Guo; Yan Liu; Jianhua Guo; Yang Zhao; Zhong Wang
Journal:  Asian J Androl       Date:  2017 May-Jun       Impact factor: 3.285

6.  Endothelial nitric oxide synthase gene polymorphisms and erectile dysfunction in chronic pain.

Authors:  Ana Segura; Pura Ballester; Raquel Ajo; María-Del-Mar Inda; Antonio Urbano; Javier Muriel; Isabel Ochando; César Margarit; Emi Martinez; Ana M Peiró
Journal:  Gene X       Date:  2019-02-02

7.  Priapism in sickle cell disease: Associations between NOS3 and EDN1 genetic polymorphisms and laboratory biomarkers.

Authors:  Camylla Vilas Boas Figueiredo; Rayra Pereira Santiago; Caroline Conceição da Guarda; Rodrigo Mota Oliveira; Luciana Magalhães Fiuza; Sètondji Cocou Modeste Alexandre Yahouédéhou; Suéllen Pinheiro Carvalho; Joelma Santana Dos Santos Neres; Antonio Mateus de Jesus Oliveira; Cleverson Alves Fonseca; Valma Maria Lopes Nascimento; Isa Menezes Lyra; Milena Magalhães Aleluia; Marilda Souza Goncalves
Journal:  PLoS One       Date:  2021-02-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.